Paper39313896
Delineating the NOX-Mediated Promising Therapeutic Strategies for the Management of Various Cardiovascular Disorders: A Comprehensive Review.
Upadhyay RK and 10 others. Curr Vasc Pharmacol, 2025. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Delineating the NOX-Mediated Promising Therapeutic Strategies for the Management of Various Cardiovascular Disorders: A Comprehensive Review. Papers, record 39313896. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39313896
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Delineating the NOX-Mediated Promising Therapeutic Strategies for the Management of Various Cardiovascular Disorders: A Comprehensive Review.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| NADPH Oxidases | Major topic |
| Cardiovascular Diseases | Major topic |
| Oxidative Stress | Major topic |
| Cardiovascular Agents | Major topic |
| Cardiovascular System | Major topic |
| Enzyme Inhibitors | Major topic |
| Antioxidants | Major topic |
| Humans | |
| Animals | |
| Reactive Oxygen Species | |
| Signal Transduction | |
| Molecular Targeted Therapy |
Source PubMed
References214
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36009488 | Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease. | Biomedicines | 2022 | https://conductscience.org/library/papers/36009488 | PubMed |
| 2 | 31487802 | Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target? | Nutrients | 2019 | https://conductscience.org/library/papers/31487802 | PubMed |
| 3 | 28626501 | NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells. | Oxid Med Cell Longev | 2017 | https://conductscience.org/library/papers/28626501 | PubMed |
| 4 | 22530599 | Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. | Antioxid Redox Signal | 2013 | https://conductscience.org/library/papers/22530599 | PubMed |
| 5 | 17237347 | The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. | Physiol Rev | 2007 | https://conductscience.org/library/papers/17237347 | PubMed |
| 6 | 15039755 | NOX enzymes and the biology of reactive oxygen. | Nat Rev Immunol | 2004 | https://conductscience.org/library/papers/15039755 | PubMed |
| 7 | 22747566 | NADPH oxidases in heart failure: poachers or gamekeepers? | Antioxid Redox Signal | 2013 | https://conductscience.org/library/papers/22747566 | PubMed |
| 8 | 18769233 | Differential vascular functions of Nox family NADPH oxidases. | Curr Opin Lipidol | 2008 | https://conductscience.org/library/papers/18769233 | PubMed |
| 9 | 19438290 | Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. | Antioxid Redox Signal | 2009 | https://conductscience.org/library/papers/19438290 | PubMed |
| 10 | 23991888 | Reactive oxygen species in inflammation and tissue injury. | Antioxid Redox Signal | 2014 | https://conductscience.org/library/papers/23991888 | PubMed |
| 11 | 12855411 | Vascular NAD(P)H oxidases: specific features, expression, and regulation. | Am J Physiol Regul Integr Comp Physiol | 2003 | https://conductscience.org/library/papers/12855411 | PubMed |
| 12 | 14588154 | Role of NADPH oxidases in the control of vascular gene expression. | Antioxid Redox Signal | 2003 | https://conductscience.org/library/papers/14588154 | PubMed |
| 13 | 16987004 | NOX2 and NOX4 mediate proliferative response in endothelial cells. | Antioxid Redox Signal | 2006 | https://conductscience.org/library/papers/16987004 | PubMed |
| 14 | 10485709 | Cell transformation by the superoxide-generating oxidase Mox1. | Nature | 1999 | https://conductscience.org/library/papers/10485709 | PubMed |
| 15 | 9405639 | Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9405639 | PubMed |
| 16 | 11483596 | A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11483596 | PubMed |
| 17 | 16771662 | NADPH oxidases in cardiovascular health and disease. | Antioxid Redox Signal | 2006 | https://conductscience.org/library/papers/16771662 | PubMed |
| 18 | 13654378 | The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. | J Biol Chem | 1959 | https://conductscience.org/library/papers/13654378 | PubMed |
| 19 | 4379032 | Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. | Experientia | 1964 | https://conductscience.org/library/papers/4379032 | PubMed |
| 20 | 14213063 | CHANGES IN THE METABOLIC PATTERN OF POLYMORPHO-NUCLEAR LEUCOCYTES DURING PHAGOCYTOSIS. | Br J Exp Pathol | 1964 | https://conductscience.org/library/papers/14213063 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42812766 | Targeting vascular inflammation and endothelial dysfunction with nanobodies: emerging therapeutic strategies for cardiovascular disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42812766 | PubMed |
| 41596076 | Beyond Radical Scavengers: Focus on NADPH Oxidases (NOX) Inhibitors as New Agents for Antioxidant Therapy in Alzheimer's Disease. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/41596076 | PubMed |
| 41389127 | Crosstalk between Ryanodine Receptor 2 Dysfunction and FK506-Binding Proteins in Pulmonary Hypertension. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/41389127 | PubMed |
| 41045403 | Unraveling the interplay between RAS axes and NOX signaling in fibroblasts during cardiac fibrosis. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/41045403 | PubMed |
| 40327837 | Impact of Hematopoietic CD14 on Oxidative Stress during Salt-Sensitive Hypertension and Kidney Injury. | J Am Soc Nephrol | 2025 | https://conductscience.org/library/papers/40327837 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DECR1 | 1666 | PubTator's text mining | https://conductscience.org/library/genes/1666 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39313896
GET https://conductscience.org/api/papers/v1/39313896/references?page=2